Literature DB >> 1349235

Immunohistochemical localization of dipeptidyl aminopeptidase IV in thyroid papillary carcinoma.

T Kotani1, J Kawano, T Suganuma, K Hirai, K Umeki, Y Aratake, K Konoe, S Ohtaki.   

Abstract

The localization of dipeptidyl aminopeptidase IV expressed aberrantly in thyroid carcinoma was studied by immunoelectron microscopy using a monoclonal antibody to the enzyme with special reference to enzyme-histochemical staining of the enzyme. Five thyroid papillary carcinomas were investigated including two lymph-node metastases. All cases showed the dense immunoreaction product on the apical membrane and only traces of the product on lateral membranes, endoplasmic reticulum and nuclear membranes. In one case only, the dense product was observed on basal tubular structures. Analysis, using immunogold labelling on pre-embedded cryosections, revealed that dipeptidyl aminopeptidase IV was localized on the luminal surface of cancer cells. Two different distribution patterns of dipeptidyl aminopeptidase IV activity staining, diffuse and apical patterns, reported previously were thought to be due to different amounts of dipeptidyl aminopeptidase IV in the cytoplasm of cancer cells. This enzyme-histochemical staining method is useful for pathological diagnosis of thyroid tumours and can be applied to clinical materials. The enzyme localization is revealed by the staining pattern.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349235      PMCID: PMC2001994     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  4 in total

1.  New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase.

Authors:  T Nagatsu; M Hino; H Fuyamada; T Hayakawa; S Sakakibara
Journal:  Anal Biochem       Date:  1976-08       Impact factor: 3.365

2.  A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide.

Authors:  V K Hopsu-Havu; G G Glenner
Journal:  Histochemie       Date:  1966

3.  Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases.

Authors:  Y Aratake; T Kotani; K Tamura; Y Araki; T Kuribayashi; K Konoe; S Ohtaki
Journal:  Am J Clin Pathol       Date:  1991-09       Impact factor: 2.493

4.  Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain.

Authors:  S Ogata; Y Misumi; Y Ikehara
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

  4 in total
  4 in total

1.  CD26 (Dipeptidyl Aminopeptidase IV) Expression in Normal and Diseased Human Thyroid Glands.

Authors:  Marcus A. Lima; Valeria A. Gontijo; Fernando C. L. Schmitt
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

2.  Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect.

Authors:  Kohji Yamada; Mutsumi Hayashi; Wenlin Du; Kei Ohnuma; Michiie Sakamoto; Chikao Morimoto; Taketo Yamada
Journal:  Cancer Cell Int       Date:  2009-06-26       Impact factor: 5.722

3.  Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription.

Authors:  Kohji Yamada; Mutsumi Hayashi; Hiroko Madokoro; Hiroko Nishida; Wenlin Du; Kei Ohnuma; Michiie Sakamoto; Chikao Morimoto; Taketo Yamada
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

4.  Altered peptidase activities in thyroid neoplasia and hyperplasia.

Authors:  Gorka Larrinaga; Lorena Blanco; Peio Errarte; Maider Beitia; Begoña Sanz; Itxaro Perez; Amaia Irazusta; Clara E Sánchez; Francisco Santaolalla; Leire Andrés; José I López
Journal:  Dis Markers       Date:  2013-11-27       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.